Summary & Overview
CPT 88165: Manual Cervical/Vaginal Cytopathology Slide Analysis and Rescreen
CPT code 88165 denotes a manual cytopathology procedure in which a laboratory analyst performs the technical examination of a cervical or vaginal cytology slide and then manually rescreens the same slide under physician supervision, using the Bethesda System for reporting. This code captures an important quality-control workflow step in cervical cancer screening and diagnostic cytology, reflecting labor-intensive manual review that can affect laboratory throughput, reporting accuracy, and payment determinations. Nationally, manual cytology and rescreening remain relevant for facilities that do not use primary automation or adjunctive molecular testing, and for cases requiring expert manual review.
Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context and service settings, typical billing considerations, and payer coverage outlines. The publication also provides benchmarks where available, notes on policy and coding updates that affect cytology services, and practical context for laboratory administrators and billing professionals.
The content emphasizes clinical and coding clarity — how the service is defined, where it is typically performed, and which payers commonly cover it. Data not provided in the input (such as specific reimbursement rates, associated taxonomies, or ICD-10 pairings) are noted as unavailable and are not fabricated here.
Billing Code Overview
CPT code 88165 describes a manual cytopathology analysis and rescreening of a cervical or vaginal slide. The procedure is performed by a laboratory analyst who completes the technical laboratory test manually, then rescreens the same slide manually under a physician's supervision, and reports results using the Bethesda System.
Service Type: Cytopathology testing (manual slide analysis and rescreening)
Typical Site of Service: Clinical laboratory or hospital laboratory
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 34-year-old woman presents to a primary care clinic for routine cervical cancer screening. A clinician collects a cervical cytology specimen (Pap smear) and submits the slide to the laboratory. In the lab, a trained cytotechnologist or laboratory analyst performs a manual microscopic review of the cervical or vaginal cytology slide using the Bethesda System, documents findings (e.g., negative for intraepithelial lesion or malignancy, ASC-US, LSIL), and then performs a manual rescreen of the same slide as a quality control step under the supervising pathologist’s oversight. The supervising physician reviews and signs out the final report. Typical workflow steps include specimen accessioning, staining (if not previously done), initial manual slide review, documentation of primary findings, manual rescreen of the same slide, reconciliation of any discrepant findings, final physician review, and release of the report to the ordering clinician. Typical sites of service are hospital laboratories, independent commercial laboratories, and outpatient pathology/cytology laboratories. Patient scenario examples include routine screening, repeat evaluation after an abnormal HPV test, or follow-up of prior atypical cytology results where manual review and rescreen are required for accurate classification using the Bethesda System.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when reporting only the physician professional component of interpretation or supervision for the cytology service. |